PDCD1 and gestational trophoblastic neoplasm: A retrospective multicenter study assessed the safety and efficacy of combining anti-PD-1 therapy with chemotherapy versus anti-PD-1 monotherapy in patients with high-risk, chemorefractory, or relapsed GTN (48).